Linda Alunkal

Chief Executive Officer at BioLattice Ophthalmics.

Earliest Form D on file: Mar 2026

Filed Mar 30, 2026

BioLattice Ophthalmics

Synthetic cornea implant to replace donor tissue

Biotech, Philadelphia PA

Signed as Chief Executive Officer

$575K

sold of $2.5M offered

Network

At BioLattice Ophthalmics

2 people

Amelia Zellander
Executive Officer, Director
Gregory Jackson
Director